KSA Asthma Practice Test

Leukotriene modifiers play a crucial role in asthma treatment by acting as antagonists to leukotrienes, which are inflammatory mediators. These chemicals are produced in the body during an asthma attack and contribute to the inflammation of the airways, leading to symptoms such as bronchoconstriction, mucus production, and airway edema. By blocking leukotrienes, these modifiers help to reduce inflammation and relax the bronchial muscles, which in turn alleviates symptoms like wheezing, shortness of breath, and chest tightness.

This mechanism helps improve overall lung function and can reduce the frequency and severity of asthma attacks. Unlike some other treatments, leukotriene modifiers do not directly enhance lung capacity or reduce the cough reflex. Instead, their primary benefit lies in mitigating the underlying inflammatory processes associated with asthma, leading to better controlled asthma symptoms.